These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2893261)

  • 1. Opioid receptor activity in the dentate region of the rat hippocampus.
    Neumaier JF; Chavkin C
    NIDA Res Monogr; 1986; 75():101-4. PubMed ID: 2893261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus.
    Neumaier JF; Mailheau S; Chavkin C
    J Pharmacol Exp Ther; 1988 Feb; 244(2):564-70. PubMed ID: 2894454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu opioid receptor activation reduces inhibitory postsynaptic potentials in hippocampal CA3 pyramidal cells of rat and guinea pig.
    Caudle RM; Chavkin C
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1361-9. PubMed ID: 1969476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal mu-receptors mediate opioid reinforcement in the CA3 region.
    Stevens KE; Shiotsu G; Stein L
    Brain Res; 1991 Apr; 545(1-2):8-16. PubMed ID: 1677606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
    Chavkin C; Henriksen SJ; Siggins GR; Bloom FE
    Brain Res; 1985 Apr; 331(2):366-70. PubMed ID: 2859095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization of opioid effects in the rat hippocampal slice.
    Valentino RJ; Dingledine R
    J Pharmacol Exp Ther; 1982 Nov; 223(2):502-9. PubMed ID: 6752374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat.
    Swearengen E; Chavkin C
    Neuropharmacology; 1989 Jul; 28(7):689-97. PubMed ID: 2569690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus.
    Wagner JJ; Caudle RM; Chavkin C
    J Neurosci; 1992 Jan; 12(1):132-41. PubMed ID: 1345943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of long-term potentiation by phencyclidine and sigma opiates in the hippocampus in vivo and in vitro.
    Stringer JL; Greenfield LJ; Hackett JT; Guyenet PG
    Brain Res; 1983 Nov; 280(1):127-38. PubMed ID: 6317141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid peptides and epileptogenesis in the limbic system: cellular mechanisms.
    Siggins GR; Henriksen SJ; Chavkin C; Gruol D
    Adv Neurol; 1986; 44():501-12. PubMed ID: 2939697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of dynorphin A(1-17)-induced place preference in rats.
    Iwamoto ET
    NIDA Res Monogr; 1989; 95():308-9. PubMed ID: 2577037
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior.
    Li D; Olszewski PK; Shi Q; Grace MK; Billington CJ; Kotz CM; Levine AS
    Brain Res; 2006 Jun; 1096(1):120-4. PubMed ID: 16716266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological effects of Mu-selective opioids on hilar neurons in the hippocampus in vivo.
    Mayer JH; Henriksen SJ
    Hippocampus; 1995; 5(6):557-68. PubMed ID: 8646282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid receptor mechanisms in the rat hippocampus.
    Chavkin C; Neumaier JF; Swearengen E
    NIDA Res Monogr; 1988; 82():94-117. PubMed ID: 2899843
    [No Abstract]   [Full Text] [Related]  

  • 16. Kappa opioid control of seizures produced by a virus in an animal model.
    Solbrig MV; Adrian R; Baratta J; Lauterborn JC; Koob GF
    Brain; 2006 Mar; 129(Pt 3):642-54. PubMed ID: 16399805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of rat globus pallidus neurons to microintophoretically applied mu and kappa opioid receptor agonists.
    Huffman RD; Frey JM
    Eur J Pharmacol; 1989 Nov; 170(3):179-91. PubMed ID: 2575994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation.
    Weisskopf MG; Zalutsky RA; Nicoll RA
    Nature; 1993 Apr; 362(6419):423-7. PubMed ID: 8096624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynorphin: analgesic effect via kappa receptors in spinal cord of the spinal cords of rats].
    Xie GX; Han JS
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):231-4. PubMed ID: 6152645
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of morphine and naloxone on hippocampal CA3 field potentials following systemic administration in the freely-moving rat.
    Linseman MA; Corrigall WA
    Brain Res Bull; 1984 Aug; 13(2):241-5. PubMed ID: 6093941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.